As of 2023, India is home to approximately 77 million adults living with diabetes, according to the International Diabetes ...

The Vietnam Insulin Patch Pumps Market was valued at USD 8.47 Million in 2024 and is projected to reach USD 14.68 Million by 2030, exhibiting a CAGR of 9.56% during the forecast period. The market is ...

Kashmiri doctor and columnist Dr Tasaduk Hussain Itoo has been honored with the prestigious Indian Achievers Award 2025 for ...

While Metformin continues to be the standard first-line treatment for Type-2 diabetes, newer therapies such as SGLT2 ...

Caring for a baby is a full-time job, often causing new mothers to overlook their own health needs. This situation is ...

A grant from the U.S. Department of Veterans Affairs (VA) will aid Wayne State University researchers in finding new insights into diabetes and its onset.

With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

There are several domestic drug companies that seem to be all prepared to transform diabetes therapy with the launch of the ...

Currently priced at Rs 60 per tablet, Empagliflozin’s generic versions will be available for as low as Rs 9-Rs 14 per tablet, significantly reducing costs for millions of patients, states the report.

A study reveals the 1-hour OGTT is a stronger, more convenient predictor of postpartum dysglycaemia than the 2-hour test.

The aspartame market was valued at $375.50 million in 2021, and is estimated to reach $561.7 million by 2031, growing at a CAGR of 3.9% from 2022 to ...

Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the ...